Quent Long Short Global Small Cap Fund LP Purchases New Stake in Intuitive Surgical, Inc. $ISRG

Quent Long Short Global Small Cap Fund LP purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 1,505 shares of the medical equipment provider’s stock, valued at approximately $852,000.

Several other hedge funds have also added to or reduced their stakes in ISRG. Rakuten Investment Management Inc. bought a new position in Intuitive Surgical in the third quarter valued at approximately $388,436,000. Assenagon Asset Management S.A. boosted its stake in Intuitive Surgical by 106.6% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after acquiring an additional 791,516 shares during the last quarter. Amundi boosted its stake in Intuitive Surgical by 29.7% in the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after acquiring an additional 739,444 shares during the last quarter. Sands Capital Management LLC boosted its stake in Intuitive Surgical by 77.0% in the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after acquiring an additional 583,539 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Intuitive Surgical by 41.3% in the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock valued at $868,212,000 after acquiring an additional 567,483 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. HSBC reduced their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a report on Wednesday. Piper Sandler reduced their price target on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research report on Wednesday. JPMorgan Chase & Co. reduced their price target on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research report on Wednesday. The Goldman Sachs Group lifted their price target on shares of Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research report on Wednesday, March 11th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and raised outlook — ISRG reported stronger?than?expected Q1 revenue and EPS, raised full?year procedure guidance and cited broad procedure adoption; that drove the initial rally after the print. Read More.
• Positive Sentiment: da Vinci 5 and innovation-led revenue — Analysts and coverage note revenues are outpacing procedures as da Vinci 5 placements and service/consumable pricing power shift growth toward innovation and value-based revenue. Read More.
• Positive Sentiment: Analysts reaffirm bullish views — several firms reiterated buy/overweight ratings and raised forecasts after the quarter, saying procedure momentum and platform adoption support longer?term upside. Read More.
• Neutral Sentiment: Market commentary highlights long?term case — investment pieces argue ISRG remains a secular winner in robotic surgery despite near?term volatility; these are thematic views rather than short?term catalysts. Read More.
• Negative Sentiment: Mixed/trimmed price targets — several banks trimmed price targets post?earnings (some materially) even while keeping buy/overweight ratings; the patchwork of cuts likely contributed to selling pressure. Read More.
• Negative Sentiment: Cybersecurity note — the company disclosed a contained cyber incident and is remediating; while management calls it contained, such disclosures can increase near?term uncertainty for investors. Read More.
• Negative Sentiment: Guidance conservatism / profit?taking — some coverage points out the company raised guidance modestly relative to the beat, which may signal conservative assumptions and prompted traders to book gains after the initial surge. Read More.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $478.82 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $427.84 and a fifty-two week high of $603.88. The stock has a market capitalization of $170.04 billion, a PE ratio of 58.04, a price-to-earnings-growth ratio of 3.78 and a beta of 1.68. The business’s 50-day simple moving average is $477.54 and its 200-day simple moving average is $515.16.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm’s revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.81 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 8.16 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.